Abstract
Cancer treatment is a major challenge in the world and, in Brazil, as in other middle-income countries (according to the World Bank), incidence rates are expected to increase by 68% by 2040. The estimate of direct costs for the treatment of cancer in Brazil (Supplementary Health and SUS) in 2020 was R$19 billion, of which R$7.8 billion were related to chemotherapy treatments. About 70% of…